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Prognostic impact of the level of neck metastasis in oral cancer patients
Abstract
Hugo Fontan Köhler1, Luiz Paulo Kowalski2
Neck staging in oral cancer depends on the number of compromised nodes, their size and side 
of occurrence.
Objective: This paper aims to evaluate risk factors for metastatic nodes in levels IV/V and their 
prognostic impact on patients with oral carcinoma.
Method: Retrospective study. Inclusion criteria: pathologist’s diagnosis of squamous cell carcinoma, 
primary tumor in the lower oral cavity, no extension into extraoral sites, no previous treatment, 
synchronous neck dissection and presence of metastatic nodes. Risk factors for metastasis were 
evaluated through logistic regression and disease-specific survival and recurrence by survival analysis. 
Classificatory analysis was performed through recursive partitioning.
Results: 307 patients met the inclusion criteria. Univariate logistic regression identified pN stage, 
vascular invasion, and multiple metastatic nodes as risk factors for metastases in levels IV/V. 
Multivariate analysis found vascular invasion and multiple metastatic nodes were significant. Survival 
analysis revealed pT, pN, neural infiltration, vascular invasion, number of metastatic nodes, metastases 
in levels IV/V, and node ratio were significant factors. In multivariate survival analysis, pT, pN, 
vascular invasion and metastases in levels IV/V were significant. Classificatory analysis showed that 
pN is non-significant in patients with level IV/V metastases.
Conclusion: The occurrence of metastases in levels IV/V was significant for disease-specific survival.
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INTRODUCTION
Squamous cell carcinomas (SCC) of the oral 
cavity are categorized in different stages to reflect 
prognostic factors and determine the most adequate 
standard course of therapy. Tumor staging looks into 
the characteristics of the primary tumor along with 
node and systemic metastases1. Neck lymph nodes 
are usually the first site affected by metastases in 
patients with high digestive tract SCC. Presence of 
metastasis is one of the most relevant prognostic 
factors for patients with oral SCC2.
Neck staging in patients with high digestive 
tract tumors is standard for most primary tumor sites 
and is based on the number of metastatic nodes, the 
size of the largest node, and the side of the involved 
node in relation to the primary tumor. Depending on 
the combination of these factors, patients are assigned 
to one of six stages3. However, this system does not 
cover all prognostic factors known to be significant, 
such as the presence of extracapsular tumor exten-
sion or lymph node density4,5. The staging system’s 
prognostic role has also been criticized due to the 
limitations it poses mainly in patients submitted to 
adjuvant therapy, for whom its discriminatory power 
is significantly diminished6.
Neck lymph nodes are grouped in levels re-
lated to well defined anatomic regions of the neck. 
Tumor involvement of neck nodes does not occur 
randomly. Patterns of involvement can be predicted 
as a function of the primary tumor site, as described 
in the literature, and used to aid in selective neck 
dissection (ND) procedures7. Node metastases in oral 
SCC occur initially on levels I to III, and that is the 
rationale for selective ND involving these levels and, 
further on, they reach levels IV and V8.
This paper aimed to analyze the risk factors 
for the presence of node metastasis on levels IV/V 
and their impact on the disease-specific survival of 
patients with oral carcinoma.
METHOD
This study enrolled patients treated consecuti-
vely at one institution from January 1985 to December 
2005. Inclusion criteria: confirmed diagnosis of SCC 
by histopathology testing, primary tumor located 
in the lower oral cavity, no tumor extension onto 
extraoral sites or onto the oropharynx, no previous 
treatment, synchronous neck dissection, and presence 
of metastatic nodes on surgical specimen. Exclusion 
criteria: patients with tumors other than SCC as con-
firmed by histopathology testing, tumors extending 
to the skin, oropharynx or other sites, patients sub-
mitted to previous treatment, primary tumor surgery 
without neck dissection, patients without metastatic 
nodes on pathology testing (pN0), patients receiving 
radiotherapy/chemoradiotherapy, and patients with 
diagnosed systemic metastasis. The staging of all 
patients was updated as per the standard procedure 
described in 20091. This study was approved by the 
Institutional Research Ethics Committee (permit nº 
571/2007).
Statistical analysis was performed on software 
program Stata 12.1 for MacOS. Categorical variables 
were described by their frequencies of occurrence, 
whereas continuous variables were described in terms 
of their mean values and standard deviations (SD). 
Logistic regression was used to correlate risk factors 
to the presence of level IV/V metastases. Survival 
analysis was done based on the Kaplan-Meier and 
Nelson-Aalen curves, combined to the Cox model. 
Classificatory analysis was performed by recursive 
partitioning, with divisions with a minimum of five 
cases and a cutoff value of 0.05. Percentages were 
rounded up to two decimal fractions and continuous 
variables to three decimal fractions. P-values equal 
to or smaller than 0.05 were deemed statistically 
significant.
RESULTS
Three-hundred and seven consecutive patients 
were included in this study. The sample had 266 
males (86.64%) and 41 females (13.36%). Age at 
diagnosis ranged between 22 and 85 years (mean: 
56.13 years; SD: 10.50 years). Primary tumor sites 
can be seen on Table 1. Primary tumors were staged 
as pT1 in nine patients (2.93%), pT2 in 112 patients 
(34.68%), pT3 in 99 patients (32.25%) and pT4a in 87 
patients (28.34%). Neck dissection was performed in 
all patients simultaneously to primary tumor ablation. 
ND on levels I-IV (supraomohyoid extended to level 
IV) was performed on 177 patients (57.65%), modi-
fied radical ND in 85 patients (27.69%), and classic 
radical ND in 45 patients (14.66%). Ninety-three pa-
tients (30.29%) underwent bilateral ND. The number 
of retrieved nodes on ipsilateral dissections ranged 
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Table 1. Primary tumor sites of the patients included in this 
series.
Primary site Number of patients Percent
Oral tongue 132 43.00%
Mouth floor 63 20.52%
Retromolar trigone 85 27.69%
Lower gum ridge 23 7.49%
Cheek mucosa 4 1.30%
Total 307 100%
Table 2. Distribution of patients as a function of neck clinical 
and pathology staging.
pN1 pN2a pN2b pN2c pN3 Total
cN0 42 3 44 7 0 96
cN1 39 2 53 14 0 108
cN2a 4 1 17 1 2 25
cN2b 8 0 31 8 1 48
cN2c 2 0 1 12 0 15
cN3 1 1 8 4 1 15
Total 96 7 154 46 4 307
from four to 116 (mean: 45.7 nodes; SD: 16.42 nodes), 
while in the contralateral neck this number ranged 
from six to 73 nodes (mean: 29.28; SD:16.99). The 
number of metastatic nodes ranged from one to 47 
in the ipsilateral neck and from none to nine on the 
contralateral neck. Node density ranged from 0.011 
to 0.979 (mean: 0.082; SD: 0.011). Clinical and pa-
thological neck staging and the distribution of stages 
can be seen on Table 2. Table 3 shows the number 
and percentage of patients with level IV/V metastases 
for each cN and pN stage. In our series, in the group 
of patients with one single metastatic node (pN1 / 
pN2a), three (2.91%) had level IV/V involvement. 
Primary tumor vascular invasion was found in 214 
patients (72.79%) and neural infiltration in 141 sub-
jects (49.13%). Patients were followed for 6.3 to 298.2 
months (mean: 44.9 months; SD: 22.4 months). At the 
end of the follow-up period, 164 patients (53.42%) 
had died of neoplastic disease.
Table 4. Multivariate analysis by logistic regression of the risk 
factor for level IV/V metastasis.
Variable Odds ratio 95% CI p-value
Vascular invasion 3.877 1.032-14.574 0.045
Involved nodes 1.484 1.287-1.710 < 0.001
CI: Confidence Interval.
Table 5. Significant variables identified in disease-specific 
survival univariate analysis.
Variable Relative risk 95% CI p-value
pT stage 1.618 1.342-1.950 < 0.001
pN stage 1.228 1.066-1.414 0.004
Level IV/V metastasis 2.624 1.717-4.008 < 0.001
Vascular invasion 1.695 1.142-2.518 0.009
Neural infiltration 1.613 1.165-2.232 0.004
Number of metastatic 
nodes 1.037 1.013-1.061 0.002
Node ratio 5.278 1.644-16.949 0.005
CI: Confidence Interval.
Univariate analysis elicited the following as 
risk factors connected to the presence of level IV/V 
metastasis: pN stage (p = 0.002), vascular invasion 
(p = 0.021), and multiple involved nodes (p < 0.001). 
In multivariate analysis, vascular invasion (p = 0.045) 
and multiple involved nodes (p < 0.001) had statistical 
significance (Table 4).
Table 3. Distribution of patients with level IV/V metastasis s a 
function of neck pathology staging.
cN Number of patients
Level IV/V 
metastasis 
(%)
pN Number of patients
Level IV/V 
metastasis 
(%)
cN0 96 7 (7.29) - - -
cN1 108 10 (9.25) pN1 96 2 (2.08)
cN2a 25 3 (12.00) pN2a 6 1 (16.67)
cN2b 48 9 (18.75) pN2b 132 22 (16.67)
cN2c 15 1 (6.67) pN2c 37 9 (24.32)
cN3 15 4 (26.67) pN3 4 0 (0)
Univariate survival analysis revealed that pT 
and pN stages, vascular invasion, neural infiltration, 
number of metastatic nodes, node ratio, and pre-
sence of metastatic nodes on levels IV and V were 
statistically significant (Table 5). These variables 
were included in a stepwise approach to multivaria-
te analysis, which revealed that pT stage, pN stage, 
vascular invasion, and node metastases on levels IV 
and V were statistically significant (Table 6). Patients 
with metastasis on levels IV and V had worse disease-
-specific survival than those with metastatic disease 
limited to levels I to III (Figure 1).
Patients with metastatic nodes on levels IV/V 
were at significantly higher risk for systemic metas-
tasis than those without neoplastic involvement in 
these levels (relative risk (RR): 3.182; 95% confiden-
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Figure 2. Nelson-Aalen cumulative risk curve for occurrence of systemic 
metastasis correlated with the presence of level IV/V metastatic nodes.
Figure 3. Nelson-Aalen cumulative risk curve for occurrence of relap-
sing neck disease correlated with the presence of level IV/V metastatic 
nodes.
Analysis by recursive partitioning including the 
presence of neck metastasis on levels IV/V and pN 
stage revealed that the latter was not significant for 
patients with metastasis on levels IV/V, although it 
was significant for patients with neoplastic involve-
ment on levels I/III (Figure 4). When patients were 
stratified as a function of the presence of metastasis 
on levels IV/V, prognostic factors varied between 
groups and it was not possible to determine which 
related to the group with neoplastic involvement on 
levels IV/V (Table 7).
Figure 1. Kaplan-Meier survival curve for patients with and without 
level IV/V metastatic nodes.
Table 6. Disease-specific survival multivariate analysis.
Variable Relative risk 95% CI p-value
pT stage 1.618 1.326-1.975 < 0.001
Level 4/5 metastasis 1.962 1.249-3.080 < 0.001
Vascular invasion 1.458 1.087-2.191 0.037
pN stage 1.447 1.041-2.011 0.028
CI: Confidence Interval.
ce interval (CI): 1.472-6.877; p = 0.003, Figure 2). 
Nonetheless, neck recurrence was not affected by 
metastases on levels IV/V (RR: 2.079; 95% CI: 0.879-
4.915; p = 0.096, Figure 3).
Figure 4. Classificatory analysis by patient recursive partitioning 
(RR: Relative Risk). All partitions with p < 0.05.
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This data is supported by another series, in 
which an incidence rate of 4.6% of level IV metastasis 
was reported after elective ND in oral SCC patients, 
with the exception of the oral tongue, in which case 
the incidence rate was 5.6%. There was no statisti-
cally significant difference on the neck relapse rates 
of patients submitted to ND for levels I-III and I-IV 
when postoperative radiotherapy was offered. Thus, 
the authors suggested that the removal of level IV 
nodes would not benefit patients14. Another series 
including oral and oropharyngeal primary tumors 
considered that managing level V was unnecessary in 
pN1 and pN2 patients due to the low incidence rates 
of metastasis observed in this area. The occurrence of 
level V metastasis in this series was significantly cor-
related to N stages above pN2b and to the presence 
of metastasis in multiple levels15. In our series, the 
incidence rate of metastasis on levels IV/V was 2.91%, 
considering patients with one involved node. This 
is a small number when compared to the threshold 
of 20% of risk of metastasis traditionally accepted in 
the indication for elective ND16. Additionally, the risk 
factors for the presence of level V metastasis were 
related to pathological characteristics available only 
on the final pathology tests.
The impact of the presence of metastasis on the 
survival of these patients is a topic that requires more 
discussion in the literature. An analysis of patients 
submitted to selective ND revealed low relapse rates 
on level V nodes. In such series it was evident that 
the presence of extracapsular extension and multiple 
metastatic nodes were the most relevant prognostic 
factors in the neck17. A retrospective series with pN2 
patients showed that the presence of node metastasis 
on levels IV/V was a significant prognostic factor for 
patient survival18. In our series this prognostic factor 
was also assessed for pN1 patients and proved to be 
statistically significant for them as well. Additionally, 
the presence of level IV/V metastasis was found to 
overwhelm all other parameters related to the N stage 
in terms of prognostic status in a classificatory analy-
sis. Therefore, this seems to be the main prognostic 
trait for patients with node involvement.
CONCLUSION
The occurrence of metastasis on levels IV/V 
correlates to the pathological characteristics of the 
primary tumor. Isolated occurrence of level IV/V 
metastasis is rare. Neoplastic involvement in levels 
Table 7. Survival multivariate analysis after patients were 
stratified according to the presence r absence of level IV/V 
metastatic nodes.
No level IV/V metastasis Present level IV/V metastasis
Variable RR (95% CI), p-value RR (95% CI), p-value
pT stage 1.654 (1.332-2.053), < 0.001 1.200 (0.555-2.591), 0.642
pN stage 1.325 (1.089-1.821), 0.015 0.870 (0.402-1.887), 0.725
Vascular 
invasion 1.583 (1.036-2.418), 0.034 0.872 (0.168-4.532), 0.870
RR: Relative Risk; CI: Confidence Interval.
DISCUSSION
Cancer patient staging is done to estimate prog-
nosis and help define the need for adjuvant therapy 
in surgery patients. For patients with oral SCC, the pN 
stage is highly significant for disease-specific survival 
and should be used to stratify these patients in trials 
due to its relevant prognostic impact9.
The extension of selective ND in oral SCC pa-
tients to include levels IV and V has been discussed 
in the literature. A paper comparing neck relapse 
rates in patients submitted to selective and radical 
ND revealed similar results for both approaches, and 
the authors concluded that the removal of nodes on 
levels I to III was sufficient10. No cases of isolated 
level IV involvement were seen in 81 oral SCC pa-
tients submitted to selective ND, thus indicating to 
the authors that node removal was not necessary in 
cN0 patients. However, the authors stressed that the 
metastasis distribution pattern is less predictable in 
cN+ patients, although no isolated level IV and V 
metastases were found. When cN0 and cN+ patients 
were compared, the rates of metastasis on level IV 
were found to be 0% and 9% respectively11. Such 
finding was not confirmed in our series, as even cN0 
patients had level IV/V involvement in 7.29% of the 
cases. Likewise, another retrospective series failed 
to find isolated level V node metastasis in patients 
with high digestive tract SCC and reported level V 
involvement in 15.1% of pN+ patients. According to 
the authors, such finding would not justify patient 
elective management12. However, in an analysis done 
on 119 elective ND procedures, the authors found 
approximately 5% of isolated level IV metastasis with 
no involvement in other levels. The authors sugges-
ted that level IV be routinely included in the neck 
dissections of cN0 and cN1 patients and that level V 
be approached for all other patients13.
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IV and V is in itself an important prognostic factor 
for patients with oral squamous cell carcinoma and 
impacts disease-specific survival, but does not affect 
neck relapse rates. This fact poses relevant impact 
upon the occurrence of systemic metastasis and must 
be taken into account in the indication of adjuvant 
therapy and, possibly, in the staging of these tumors.
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